🟢 10x Genomics is trading 5% up with no clear company-specific catalyst identified

10x Genomics is trading at $76.61, up 5.00%, with no clear company-specific announcement explaining the October 27 move.

• The company’s investor news page lists its October 7 collaboration as its latest release.
• The October 23 Stephens downgrade predates the move and does not explain the gain.
• Provided market context shows modest index moves; broad-market strength alone is not an established explanation. No volume or activity data was available.